Cargando…

Deciphering the late steps of rifamycin biosynthesis

Rifamycin-derived drugs, including rifampin, rifabutin, rifapentine, and rifaximin, have long been used as first-line therapies for the treatment of tuberculosis and other deadly infections. However, the late steps leading to the biosynthesis of the industrially important rifamycin SV and B remain l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Feifei, Lei, Chao, Li, Fengwei, Zhang, Xingwang, Wang, Jin, Zhang, Wei, Fan, Zhen, Li, Weichao, Tang, Gong-Li, Xiao, Youli, Zhao, Guoping, Li, Shengying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002545/ https://www.ncbi.nlm.nih.gov/pubmed/29904078 http://dx.doi.org/10.1038/s41467-018-04772-x

Ejemplares similares

Characterization of the Rifamycin-Degrading Monooxygenase From Rifamycin Producers Implicating Its Involvement in Saliniketal Biosynthesis
por: Zheng, Xiao-Fu, et al.
Publicado: (2020)

GlnR Dominates Rifamycin Biosynthesis by Activating the rif Cluster Genes Transcription Both Directly and Indirectly in Amycolatopsis mediterranei
por: Liu, Xinqiang, et al.
Publicado: (2020)

A feedback regulatory model for RifQ-mediated repression of rifamycin export in Amycolatopsis mediterranei
por: Lei, Chao, et al.
Publicado: (2018)

Structure-guided manipulation of the regioselectivity of the cyclosporine A hydroxylase CYP-sb21 from Sebekia benihana
por: Li, Fengwei, et al.
Publicado: (2020)

Study on Dissolution Thermodynamics and Cooling Crystallization of Rifamycin S
por: Chen, Kui, et al.
Publicado: (2021)

Cytochrome P450s in algae: Bioactive natural product biosynthesis and light-driven bioproduction
por: Zheng, Shanmin, et al.
Publicado: (2022)

Early and Late Steps of Quinine Biosynthesis
por: Trenti, Francesco, et al.
Publicado: (2021)

Rifamycin O, An Alternative Anti-Mycobacterium abscessus Agent
por: Hanh, Bui Thi Bich, et al.
Publicado: (2020)

Generation of Tetracycline and Rifamycin Resistant Chlamydia Suis Recombinants
por: Marti, Hanna, et al.
Publicado: (2021)

Stability of Non-Ionic Surfactant Vesicles Loaded with Rifamycin S
por: Marchianò, Verdiana, et al.
Publicado: (2022)

Three pairs of surrogate redox partners comparison for Class I cytochrome P450 enzyme activity reconstitution
por: Liu, Xiaohui, et al.
Publicado: (2022)

Redesign of Rifamycin Antibiotics to Overcome ADP‐Ribosylation‐Mediated Resistance
por: Lan, Tian, et al.
Publicado: (2022)

Promise and Peril of Pretomanid–Rifamycin Regimens for Drug-susceptible Tuberculosis
por: Velásquez, Gustavo E., et al.
Publicado: (2023)

Blocking ADP-ribosylation expands the anti-mycobacterial spectrum of rifamycins
por: Ganapathy, Uday S., et al.
Publicado: (2023)

8-Deoxy-Rifamycin Derivatives from Amycolatopsis mediterranei S699 ΔrifT Strain
por: Ye, Feng, et al.
Publicado: (2020)

Draft Genome Sequence of the Rifamycin Producer Amycolatopsis rifamycinica DSM 46095
por: Saxena, Anjali, et al.
Publicado: (2014)

Deciphering the Substrate Specificity of SbnA, the Enzyme Catalyzing the First Step in Staphyloferrin B Biosynthesis
por: Kobylarz, Marek J., et al.
Publicado: (2016)

Induction and autoinduction properties of rifamycin derivatives: a review of animal and human studies.
por: Strolin Benedetti, M, et al.
Publicado: (1994)

Integrative metagenomic and biochemical studies on rifamycin ADP-ribosyltransferases discovered in the sediment microbiome
por: Shin, Jae Hong, et al.
Publicado: (2018)

Hepatocytic transcriptional signatures predict comparative drug interaction potential of rifamycin antibiotics
por: Dyavar, Shetty Ravi, et al.
Publicado: (2020)

C25-modified rifamycin derivatives with improved activity against Mycobacterium abscessus
por: Paulowski, Laura, et al.
Publicado: (2022)

State of the Art on Developments of (Bio)Sensors and Analytical Methods for Rifamycin Antibiotics Determination
por: Noor, Hassan, et al.
Publicado: (2023)

An in silico analysis of rpoB mutations to affect Chlamydia trachomatis sensitivity to rifamycin
por: Benamri, Ichrak, et al.
Publicado: (2022)

Rifamycin W Analogues from Amycolatopsis mediterranei S699 Δrif-orf5 Strain
por: Shi, Yanrong, et al.
Publicado: (2021)

Deciphering and reprogramming the cyclization regioselectivity in bifurcation of indole alkaloid biosynthesis
por: Wang, Zhuo, et al.
Publicado: (2022)

Risk Factors for Acquired Rifamycin and Isoniazid Resistance: A Systematic Review and Meta-Analysis
por: Rockwood, Neesha, et al.
Publicado: (2015)

Rifamycin SV-MMX® as the recommended self-treatment for moderate to severe travellers’ diarrhoea: reply
por: Steffen, Robert, et al.
Publicado: (2019)

Kanglemycin A Can Overcome Rifamycin Resistance Caused by ADP-Ribosylation by Arr Protein
por: Harbottle, John, et al.
Publicado: (2021)

Deciphering the Molecular Functions of Sterols in Cellulose Biosynthesis
por: Schrick, Kathrin, et al.
Publicado: (2012)

Engineering Bafilomycin High-Producers by Manipulating Regulatory and Biosynthetic Genes in the Marine Bacterium Streptomyces lohii
por: Li, Zhong, et al.
Publicado: (2021)

Draft Genome Sequence of Rifamycin Derivatives Producing Amycolatopsis mediterranei Strain DSM 46096/S955
por: Singh, Priya, et al.
Publicado: (2014)

Correction: Risk Factors for Acquired Rifamycin and Isoniazid Resistance: A Systematic Review and Meta-Analysis
Publicado: (2015)

Rifamycin congeners kanglemycins are active against rifampicin-resistant bacteria via a distinct mechanism
por: Peek, James, et al.
Publicado: (2018)

Blocking Bacterial Naphthohydroquinone Oxidation and ADP-Ribosylation Improves Activity of Rifamycins against Mycobacterium abscessus
por: Ganapathy, Uday S., et al.
Publicado: (2021)

Rifamycin-Related Polyketides from a Marine-Derived Bacterium Salinispora arenicola and Their Cytotoxic Activity
por: Van Anh, Cao, et al.
Publicado: (2023)

Shorter-course treatment for Mycobacterium ulcerans disease with high-dose rifamycins and clofazimine in a mouse model of Buruli ulcer
por: Converse, Paul J., et al.
Publicado: (2018)

Intermediates in monensin biosynthesis: A late step in biosynthesis of the polyether ionophore monensin is crucial for the integrity of cation binding
por: Hüttel, Wolfgang, et al.
Publicado: (2014)

Biosynthesis of trioxacarcin revealing a different starter unit and complex tailoring steps for type II polyketide synthase
por: Zhang, Mei, et al.
Publicado: (2015)

Comparison of Rifamycins for Efficacy Against Mycobacterium avium Complex and Resistance Emergence in the Hollow Fiber Model System
por: Boorgula, Gunavanthi D., et al.
Publicado: (2021)

Effect of Genetic Variations in Drug-Metabolizing Enzymes and Drug Transporters on the Pharmacokinetics of Rifamycins: A Systematic Review
por: Sileshi, Tesemma, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5i42bnln6hsc8ko49hccg15ksi